FI111944B - Menetelmä farmakologisesti aktiivisten trisyklisten bentsatsepiinien valmistamiseksi - Google Patents

Menetelmä farmakologisesti aktiivisten trisyklisten bentsatsepiinien valmistamiseksi Download PDF

Info

Publication number
FI111944B
FI111944B FI954229A FI954229A FI111944B FI 111944 B FI111944 B FI 111944B FI 954229 A FI954229 A FI 954229A FI 954229 A FI954229 A FI 954229A FI 111944 B FI111944 B FI 111944B
Authority
FI
Finland
Prior art keywords
methyl
benzazepine
tetrahydro
nmr
ppm
Prior art date
Application number
FI954229A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954229A0 (fi
FI954229A (fi
Inventor
Rolf Hohlweg
Erik Bardrum Nielsen
Original Assignee
Cenes Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd filed Critical Cenes Ltd
Publication of FI954229A0 publication Critical patent/FI954229A0/fi
Publication of FI954229A publication Critical patent/FI954229A/fi
Application granted granted Critical
Publication of FI111944B publication Critical patent/FI111944B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI954229A 1993-03-10 1995-09-08 Menetelmä farmakologisesti aktiivisten trisyklisten bentsatsepiinien valmistamiseksi FI111944B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK93267A DK26793D0 (da) 1993-03-10 1993-03-10 Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling
DK26793 1993-03-10
DK9400069 1994-02-18
PCT/DK1994/000069 WO1994020472A1 (en) 1993-03-10 1994-02-18 Heterocyclic compounds, their use and preparation

Publications (3)

Publication Number Publication Date
FI954229A0 FI954229A0 (fi) 1995-09-08
FI954229A FI954229A (fi) 1995-09-08
FI111944B true FI111944B (fi) 2003-10-15

Family

ID=8091615

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954229A FI111944B (fi) 1993-03-10 1995-09-08 Menetelmä farmakologisesti aktiivisten trisyklisten bentsatsepiinien valmistamiseksi

Country Status (19)

Country Link
US (1) US5512562A (el)
EP (1) EP0688320B1 (el)
JP (1) JP3779319B2 (el)
KR (1) KR960701022A (el)
CN (1) CN1045957C (el)
AT (1) ATE179700T1 (el)
AU (1) AU682494B2 (el)
CA (1) CA2157668C (el)
DE (1) DE69418321T2 (el)
DK (2) DK26793D0 (el)
ES (1) ES2133542T3 (el)
FI (1) FI111944B (el)
GR (1) GR3030864T3 (el)
IL (1) IL108730A (el)
NO (1) NO953543L (el)
NZ (1) NZ262098A (el)
TW (1) TW279861B (el)
WO (1) WO1994020472A1 (el)
ZA (1) ZA941377B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745815B1 (fr) * 1996-03-08 1998-06-26 Synthelabo Derives de benzofurane, leur preparations et compositions pharmaceutiques les comprenant
AU2030197A (en) * 1996-03-08 1997-09-22 Synthelabo 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
FR2752840A1 (fr) * 1996-08-29 1998-03-06 Synthelabo Derives de benzothiophene, leur preparation et leur application en therapeutique
AU742873B2 (en) * 1997-03-12 2002-01-17 Addex Pharma Sa Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
US6528529B1 (en) * 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
WO2000000203A1 (en) * 1998-06-30 2000-01-06 Eli Lilly And Company Azepine derivatives having effects on serotonin related systems
JP2005522408A (ja) 2001-07-13 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 5−HT受容体リガントとしてのヘキサヒドロアゼピノ(4,5−g)インドールおよびインドリン
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
GB0414795D0 (en) * 2004-07-01 2004-08-04 Glaxo Group Ltd Compounds
KR101781789B1 (ko) * 2010-01-27 2017-09-26 에이비 파르마 리미티드. C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물
KR20150108840A (ko) * 2012-12-21 2015-09-30 에이비티 홀딩 컴퍼니 세로토닌 5-ht2c 수용체 리간드로서 벤즈아제핀 및 그의 용도
CN105566262B (zh) * 2016-01-11 2017-10-27 华东理工大学 苯并呋喃‑7‑烷基胺类化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
CA1234110A (en) * 1983-08-12 1988-03-15 Joel G. Berger Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK157925C (da) * 1985-04-22 1990-08-27 Novo Industri As 2,3,4,5-tetrahydro-1h-3-benzazepinderivater og farmaceutiske praeparater indeholdende disse

Also Published As

Publication number Publication date
CA2157668C (en) 2006-05-30
DK26793D0 (da) 1993-03-10
FI954229A0 (fi) 1995-09-08
JPH08507498A (ja) 1996-08-13
AU6138694A (en) 1994-09-26
ES2133542T3 (es) 1999-09-16
NO953543D0 (no) 1995-09-08
DE69418321T2 (de) 1999-12-30
CA2157668A1 (en) 1994-09-15
NO953543L (no) 1995-09-08
KR960701022A (ko) 1996-02-24
AU682494B2 (en) 1997-10-09
DE69418321D1 (de) 1999-06-10
EP0688320A1 (en) 1995-12-27
US5512562A (en) 1996-04-30
CN1045957C (zh) 1999-10-27
TW279861B (el) 1996-07-01
ZA941377B (en) 1995-08-28
IL108730A (en) 1999-08-17
EP0688320B1 (en) 1999-05-06
DK0688320T3 (da) 1999-11-01
IL108730A0 (en) 1994-05-30
GR3030864T3 (en) 1999-11-30
NZ262098A (en) 1996-11-26
FI954229A (fi) 1995-09-08
WO1994020472A1 (en) 1994-09-15
JP3779319B2 (ja) 2006-05-24
ATE179700T1 (de) 1999-05-15
CN1121710A (zh) 1996-05-01

Similar Documents

Publication Publication Date Title
FI111944B (fi) Menetelmä farmakologisesti aktiivisten trisyklisten bentsatsepiinien valmistamiseksi
WO1997047601A1 (fr) Composes heterocycliques fusionnes et leurs utilisations medicinales
DE60127434T2 (de) Benzoxazinonderivative, deren herstellung und verwendung
WO2006103559A1 (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
NO173865B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,3,4,5-tetrahydro-1h-3-benzazepiner
FI67851B (fi) Foerfarande foer framstaellning av nya dopaminagonistiskt verkande benso(4,5)pyrano(2,3c)pyrrolderivat
AU778796B2 (en) Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
AU767332B2 (en) Dopamine D1 receptor agonist compounds
JPH0657709B2 (ja) モルホリン誘導体、その製造方法およびそれを含有する医薬組成物
FI94956C (fi) Menetelmä uusien terapeuttisesti aktiivisten 7-metoksimetyylioksi-2,3,4,5-tetrahydro-1H-3-bentsatsepiinien valmistamiseksi
IL104657A (en) History of benzapine, their preparation and the pharmaceutical preparations containing them
CZ211094A3 (en) Naphthoxazines, process of their preparation, their use as medicaments and pharmaceutical compositions containing those naphthoxazines
JP3034556B2 (ja) 医薬用化合物類
MXPA02003849A (es) Nuevos compuestos de pirimidin-4-ona, un proceso para su preparacion y las composiciones farmaceuticas que los contienen.
CA2010059A1 (en) Benzazepines
ZA200303118B (en) Benzoxazinone derivatives, their preparation and use.
IE67793B1 (en) Antipsychotic benzodioxan derivatives
KR20010072407A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도

Legal Events

Date Code Title Description
MM Patent lapsed